Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors

European Journal of Medicinal Chemistry
2014.0

Abstract

A series of diphenylmethylamine derivatives were rationally designed, synthesized and biologically evaluated. Most of them exhibited moderate to good Akt1 inhibitory activities, as well as promising anti-proliferative efficacy against cancer cell lines. Besides, molecular docking studies were carried out to probe their binding modes with Akt1. Further kinase selectivity studies of compound 22c were performed, indicating its excellent selectivity against Aurora A, Drak, IKKβ, GSK3β, SYK and JAK2, and moderate selectivity against PKC and BRAF. Finally, a refined pharmacophore model was generated using the most active compounds 2, 12c and 22c via application of HipHop program.

DOI： 10.1016/j.ejmech.2013.11.036

Knowledge Graph

Similar Paper

Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors
European Journal of Medicinal Chemistry 2014.0
Design of Selective, ATP-Competitive Inhibitors of Akt
Journal of Medicinal Chemistry 2010.0
Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents
Bioorganic & Medicinal Chemistry 2012.0
Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery of trans-3,4′-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and biological evaluation of pyrazol-furan carboxamide analogues as novel Akt kinase inhibitors
European Journal of Medicinal Chemistry 2016.0
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and biological evaluation of 2-methyl-(1,1′-biphenyl)-pyrimidine conjugates
Bioorganic & Medicinal Chemistry Letters 2020.0
Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors
European Journal of Medicinal Chemistry 2010.0
Discovery of 4-aminoquinazoline—urea derivatives as Aurora kinase inhibitors with antiproliferative activity
Bioorganic & Medicinal Chemistry 2014.0